Intraocular stability of phakic IOL models may affect long-term results of IOL interaction with surrounding tissue

Article

The intraocular position of different models of phakic IOLs show differences in space to the crystalline lens and the corneal endothelium, which may affect long-term results in terms of IOL interaction with surrounding tissue, according to a study published in the January 2008 issue of the Journal of Cataract & Refractive Surgery.

The intraocular position of different models of phakic IOLs show differences in space to the crystalline lens and the corneal endothelium, which may affect long-term results in terms of IOL interaction with surrounding tissue, according to a study published in the January 2008 issue of the Journal of Cataract & Refractive Surgery.

Thomas Kohnen, MD and team from the Johann Wolfgang Goethe-University, Germany, evaluated the postoperative intraocular positional stability of one rigid polymethylmethacrylate (PMMA) phakic IOL model and two foldable polysilicone-PMMA iris-fixated phakic IOL models.

One of three iris-fixated phakic IOL models (Artisan, Artiflex I, and Artiflex II; Ophtec BV) was implanted in 45 eyes of 26 patients with myopia or myopic astigmatism; each model was implanted in 15 eyes. The central distance between the phakic IOL and corneal endothelium and between the phakic IOL and anterior surface of the crystalline lens was evaluated using Scheimpflug photography six and 12 months after surgery.

The mean preoperative spherical equivalent was -9.32D±1.78 (SD) (range -6.5 to -13.5 D). The median distance from the central corneal endothelium to the anterior surface of the phakic IOL at six months and 12 months was 2.65 mm and 2.64 mm, respectively, in the Artisan group, 2.47 mm and 2.50 mm, respectively, in the Artiflex I group, and 2.48 mm and 2.52 mm, respectively, in the Artiflex II group. The median distance between the posterior surface of the phakic IOL and the anterior surface of the crystalline lens at six months and 12 months was 0.40 mm and 0.48 mm, respectively, in the Artisan group, 0.53 mm and 0.55 mm, respectively, in the Artiflex I group, and 0.68 mm and 0.66 mm, respectively, in the Artiflex II group. At 12 months, the distance between the phakic IOL and crystalline lens was statistically significantly greater in the Artiflex II group than in the Artisan group (p<0.01).

From these results, the researchers concluded that the intraocular position of rigid phakic IOLs and foldable silicone iris-supported phakic IOLs varied between the three phakic IOL models in space to the crystalline lens and the corneal endothelium, which has long-term implications in terms of IOL interaction with surrounding tissue.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.